The rapid advancement of Next-Generation Sequencing (NGS) has opened a wealth of opportunities for research in many fields: cancer biology, epigenetics, tumor evolution, microbiome and infectious disease dynamics, neuro-degeneration, personalized medicine, and improved diagnosis and risk assessment for patients. Moreover, there are emerging, faster NGS technologies that promise comprehensive molecular portraits of disease and actionable clinical results for doctors within a single day. Scientists and physicians will be better equipped to design studies and help patients if they possess an intricate knowledge of these molecular-profiling methods, their biological context, and their applicability to specific cases and diseases. Finally, a rich understanding of the complexity of the human genome is essential for the proper annotation of characterization of any new mutations/modifications found, since large-scale efforts at tumor and normal genome sequencing have dramatically altered our view of the “normal” genome and epigenome.
Thus, in this course, students will build a strong foundation of knowledge of high-throughput and NGS technologies (both existing and emerging), learn the applications of these technologies for basic and clinical research, and finally learn the essential tools for the analysis, integration, and application of these data relative to other public databases and phenotype repositories. Students will learn, first-hand, how to analyze and integrate data from: whole genome sequencing, RNA-sequencing, epigenome data (RRBS/ATAC-seq), proteomics data (LC-MS), microbiome, metagenomic, and cancer data, and then compare them to public repositories.
We have a broad range of expertise being contributed from many leaders in the field, including:
Doron Betel, Ph.D., Weill Cornell Medicine
Joel Dudley, Ph.D., Mount Sinai School of Medicine
Olivier Elemento, Ph.D., Weill Cornell Medicine
Sheng Li, Ph.D., The Jackson Labratory
Elizabeth Henaff, Ph.D., Weill Cornell Medicine
Ekta Khurana, Ph.D., Weill Cornell Medicine
Ross Levine, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center
Gholson Lyon, M.D., Ph.D., Cold Spring Harbor Laboratory
Christopher Mason, Ph.D., Weill Cornell Medicine
Ari Melnick, M.D., Weill Cornell Medicine
Andrea Sboner, Ph.D., Weill Cornell Medicine
Shijia Zhu, Ph.D., Mount Sinai School of Medicine
Marcin Imielinski, M.D., Ph.D., New York Genome Center and Weill Cornell Medicine
Deborah Estrin, Ph.D., Cornell Tech
[03.15.2017] Welcome to the Class!